CClinicalTrials.gg
CompletedNCT03925077SCIPEUpdated Feb 5, 2026Results posted

Spinal Cord Injury Program in Exercise

An interventional study of Movement-to-Music and Standard Exercise Training in Spinal Cord Injuries, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to examine two 8-week, remotely delivered exercise interventions: Movement-to-Music (M2M) and Standard Exercise Training (SET), with 327 adults with spinal cord injury. Enrolled participants will be randomized into one of three groups: a) M2M, b) SET, and c) attention control (AC).

Read the detailed description

The purpose of the Spinal Cord Injury Program in Exercise (SCIPE) study is to examine two 8-week, remotely delivered exercise interventions: Movement-to-Music (M2M) and Standard Exercise Training (SET), with 327 adults with SCI. The primary aim is to examine change in physical activity level after the 8-week M2M and SET interventions. We hypothesize that participants in M2M and SET will have significant increase in physical activity compared to an Attention Control (AC) group after the 8-week intervention. The secondary aim is to examine effects of the M2M and SET interventions on health and quality of life outcomes. We hypothesize that participants in M2M and SET will have significant increases in sleep quality and quality of life and decreases in pain and fatigue compared to AC after the 8-week intervention. Exercise enjoyment in M2M and SET participants will also be explored. The tertiary aim is to evaluate the demographic (age, race, sex), clinical (level of injury, type of injury), and psychosocial (social support, outcome expectations, self-efficacy, self-regulation) variables of two participant groups: 1) compliant participants who completed ≥ 50% of the intervention, and 2) noncompliant participants who completed post-testing but \< 50% of the intervention or who did not complete post-testing.

02

Conditions studied

  • Spinal Cord Injuries
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 96 is above the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Diagnosed with a SCI resulting in incomplete or complete (C5 and below) paraplegia or tetraplegia;
  2. Demonstrate readiness to physical activity by completing the Physical Activity Readiness Questionnaire for Everyone (PAR-Q+);
  3. Obtain medical clearance if required by PAR-Q+;
  4. Converse in and read English.

Exclusion criteria

Exclusion Criteria:

  1. No broadband internet access;
  2. Significant visual impairment that prevents seeing a computer screen to follow a home exercise program;
  3. Currently pregnant.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
96 participants (actual)

Study arms

  • Active comparator
    Phase 1: Movement-to-Music (M2M)

    All M2M sessions are delivered using videos uploaded to a secure study website (the SCIPE website). Participants in M2M will have access to the website and attend three 60-minute M2M sessions per week for a total of 8 weeks. Each session provides rhythmic-based exercises that are choreographed to music to target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website.

    Other: Movement-to-Music

  • Active comparator
    Phase 1: Standard Exercise Training (SET)

    All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website.

    Other: Standard Exercise Training

  • No intervention
    Phase 1: Attention Control (AC)

    Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.

  • Active comparator
    Phase 2: Standard Exercise Training (SET)

    All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website.

    Other: Standard Exercise Training

  • No intervention
    Phase 2: Attention Control (AC)

    Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.

Interventions

  • OtherMovement-to-Music

    The M2M program has been developed for onsite instruction and will be repurposed into an eHealth version. The program is based on the positive effects of exercise and music on both physiological and psychosocial outcomes in people with disabilities. Investigators aim to advance our current M2M program by enabling more robust personalization features, allowing people with SCI to individualize their M2M program. Movement and tempo-based adaptations will also be available. A typical M2M session will consist of tailored movement routines starting with a warmup using range of motion exercises, followed by muscle strengthening, cardiorespiratory, and/or balance routines, and ending with a cool down emphasizing breathing and mindfulness.

    Also known as: M2M

  • OtherStandard Exercise Training

    The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.

    Also known as: SET

06

What researchers measure

Primary outcomes

  1. Physical Activity Level at Week 8

    Physical activity was assessed using the Leisure Time Physical Activity Questionnaire for People with Spinal Cord Injury (LTPAQ-SCI). The LTPAQ-SCI is a 3-item, self-report questionnaire that measures the minutes people with spinal cord injury spend in mild, moderate, and heavy intensity leisure time physical activity in the last 7 days.

    Time frame: Post 8-week intervention

Secondary outcomes

  1. Pain Intensity Week 8

    The pain intensity was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Intensity Adult Short Form 3a (v1.0). The instrument is a 3-item measure with the response scores ranging from 1 (Had no pain) to 5 (Very severe). The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis. Higher scores indicate higher pain intensity.

    Time frame: Post 8-week intervention

  2. Pain Interference at Week 8

    The influence of pain on performing daily activities was assessed with the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Interference Adult Short Form 8a (v1.0). The form contains 8 items with 5 response options ranging from 1 (Not at all) to 5 (Very much). The form has raw scores range from 8 to 40, with higher scores indicating more pain interference. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

    Time frame: Post 8-week intervention

  3. Sleep Quality at Week 8

    Sleep quality is assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Sleep Disturbance Adult Short Form 8a, which contains 8 items on a 5-point Likert scale, ranging from 1 (Very much) to 5 (Not at all). The form has raw scores range from 8 to 40, with higher scores indicating worst sleep quality. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

    Time frame: Post 8 week intervention

  4. Fatigue Level at Week 8

    Fatigue was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue Adult Short Form. The instrument is a 8 items on a 5-point Likert scale, ranging from 1 (Not at all/Never) to 5 (Very much/Always). Higher scores indicate higher fatigue. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

    Time frame: Post 8-week intervention

  5. Health-related Physical Quality of Life at Week 8

    Health-related quality of life was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) 10 Global Health Items. The Global-10 Health form is a 10-item measure with the response scores ranging from 1 (Poor/Not at all/Always/Very severe) to 5 (Excellent/Completely/Never/None). One question item, "how would you rate your pain on average?", is on a 11-point Likert scale that ranges from 0 (No pain) to 10 (Worst pain imaginable). Higher scores indicate better health-related quality of life. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

    Time frame: Post 8-week intervention

  6. Ability to Participate in Social Roles and Activities at Week 8

    Social participation was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Ability to Participate in Social Roles and Activities Short Form 8a. The instrument is a 8-item measure with the response scores ranging from 1 (always) to 5 (never). The lowest possible total raw score is 8 and the highest possible score is 40. Higher scores indicate better ability to participate in social roles and activities. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.each participant for analysis.

    Time frame: Post 8-week intervention

07

Results

Posted Feb 5, 2026
Limitations and caveats
Because the interventions were delivered asynchronously, it was challenging to verify whether participants consistently completed the exercises or engaged with the videos and articles. Maintaining long-term engagement after the intervention also proved challenging, highlighting the need for future research to identify factors contributing to attrition and to develop strategies that promote sustained participation.

Participant flow

Participants were recruited through social media platforms (e.g., Instagram, Facebook) and word of mouth. Recruitment for the Feasibility Phase took place between February 2021 and March 2022. Recruitment for the Effectiveness Phase occurred between August 2023 and September 2024. Recruitment and enrollment for both study phases were performed separately.

Feasibility Phase
Participant flow — Feasibility Phase
MilestonePhase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Started12121200
8-week assessment8101000
12-week assessment58900
16-week assessment58800
Completed58800
Not completed74400
Withdrew: Lost to follow-up74400
Effectiveness Phase
Participant flow — Effectiveness Phase
MilestonePhase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Started0003030
8-week assessment0001923
12-week assessment0002222
16-week assessment0002122
Completed0002122
Not completed00098
Withdrew: Lost to follow-up00098

Outcome measures

PrimaryPhysical Activity Level at Week 8

Physical activity was assessed using the Leisure Time Physical Activity Questionnaire for People with Spinal Cord Injury (LTPAQ-SCI). The LTPAQ-SCI is a 3-item, self-report questionnaire that measures the minutes people with spinal cord injury spend in mild, moderate, and heavy intensity leisure time physical activity in the last 7 days.

Time frame:
Post 8-week intervention
Reported as:
Mean · Minutes per week
Physical Activity Level at Week 8
Minutes per weekPhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Physical Activity Level at Week 8383 ± 347297 ± 227
SecondaryPain Intensity Week 8

The pain intensity was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Intensity Adult Short Form 3a (v1.0). The instrument is a 3-item measure with the response scores ranging from 1 (Had no pain) to 5 (Very severe). The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis. Higher scores indicate higher pain intensity.

Time frame:
Post 8-week intervention
Reported as:
Mean · T-score
Pain Intensity Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Pain Intensity Week 853.5 ± 10.656.3 ± 9.9
SecondaryPain Interference at Week 8

The influence of pain on performing daily activities was assessed with the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Interference Adult Short Form 8a (v1.0). The form contains 8 items with 5 response options ranging from 1 (Not at all) to 5 (Very much). The form has raw scores range from 8 to 40, with higher scores indicating more pain interference. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Time frame:
Post 8-week intervention
Reported as:
Mean · T-score
Pain Interference at Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Pain Interference at Week 853.6 ± 8.555.5 ± 8.9
SecondarySleep Quality at Week 8

Sleep quality is assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Sleep Disturbance Adult Short Form 8a, which contains 8 items on a 5-point Likert scale, ranging from 1 (Very much) to 5 (Not at all). The form has raw scores range from 8 to 40, with higher scores indicating worst sleep quality. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Time frame:
Post 8 week intervention
Reported as:
Mean · T-score
Sleep Quality at Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Sleep Quality at Week 851.7 ± 5.652.7 ± 5.6
SecondaryFatigue Level at Week 8

Fatigue was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue Adult Short Form. The instrument is a 8 items on a 5-point Likert scale, ranging from 1 (Not at all/Never) to 5 (Very much/Always). Higher scores indicate higher fatigue. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Time frame:
Post 8-week intervention
Reported as:
Mean · T-score
Fatigue Level at Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Fatigue Level at Week 850.1 ± 10.555.1 ± 9.7
SecondaryHealth-related Physical Quality of Life at Week 8

Health-related quality of life was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) 10 Global Health Items. The Global-10 Health form is a 10-item measure with the response scores ranging from 1 (Poor/Not at all/Always/Very severe) to 5 (Excellent/Completely/Never/None). One question item, "how would you rate your pain on average?", is on a 11-point Likert scale that ranges from 0 (No pain) to 10 (Worst pain imaginable). Higher scores indicate better health-related quality of life. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Time frame:
Post 8-week intervention
Reported as:
Mean · T-score
Health-related Physical Quality of Life at Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Health-related Physical Quality of Life at Week 843.6 ± 8.541.3 ± 6.8
SecondaryAbility to Participate in Social Roles and Activities at Week 8

Social participation was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Ability to Participate in Social Roles and Activities Short Form 8a. The instrument is a 8-item measure with the response scores ranging from 1 (always) to 5 (never). The lowest possible total raw score is 8 and the highest possible score is 40. Higher scores indicate better ability to participate in social roles and activities. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.each participant for analysis.

Time frame:
Post 8-week intervention
Reported as:
Mean · T-score
Ability to Participate in Social Roles and Activities at Week 8
T-scorePhase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)
Ability to Participate in Social Roles and Activities at Week 850.3 ± 9.045.4 ± 9.4

Adverse events

Collected over From enrollment until end of week-16 follow up. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Phase 1: Movement-to-Music (M2M)0/12 (0%)0/12 (0%)0/12 (0%)
Phase 1: Standard Exercise Training (SET)0/12 (0%)0/12 (0%)0/12 (0%)
Phase 1: Attention Control (AC)0/12 (0%)0/12 (0%)0/12 (0%)
Phase 2: Standard Exercise Training (SET)0/30 (0%)0/30 (0%)0/30 (0%)
Phase 2: Attention Control (AC)0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

We report baseline characteristics of participants in the Effectiveness phase here. Approval was received from the program officer to remove the M2M arm from the Effectiveness phase, after completing the Feasibility phase with the 3 study arms (M2M, SET, and AC).

Age, Continuous
Age, Continuous(Years)Phase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)Total
Mean42.0 ± 11.647.7 ± 11.846.4 ± 12.049.5 ± 10.847.3 ± 12.347.3 ± 11.6
Sex: Female, Male
Sex: Female, Male(Participants)Phase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)Total
Female658201756
Male674101340
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Phase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)Total
Hispanic or Latino1124210
Not Hispanic or Latino11119262885
Unknown or Not Reported001001
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Phase 1: Movement-to-Music (M2M)Phase 1: Standard Exercise Training (SET)Phase 1: Attention Control (AC)Phase 2: Standard Exercise Training (SET)Phase 2: Attention Control (AC)Total
American Indian or Alaska Native002002
Asian100012
Native Hawaiian or Other Pacific Islander000000
Black or African American1227618
White10106202268
More than one race000303
Unknown or Not Reported002013
08

Study locations

1 site
  • RecTech Center
    Birmingham, Alabama 35209, United States
09

References and documents

Publications

  • Young HJ, Mehta T, Kim Y, Padalabalanarayanan S, Chiu CY, Rimmer JH, Thirumalai M. The Spinal Cord Injury Program in Exercise (SCIPE) study: study protocol for a randomized controlled trial evaluating teleexercise programs for people with spinal cord injury. Trials. 2021 Aug 19;22(1):551. doi: 10.1186/s13063-021-05474-4. PubMed 34412653 ↗

Study documents

  • Protocol, analysis plan and consent form · Jul 22, 2023

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03925077
Lead sponsor
University of Alabama at Birmingham
Responsible party
Hui-Ju Young, PhD (Scientist, University of Alabama at Birmingham) — Principal investigator
First posted
Apr 23, 2019
Start date
Feb 1, 2021
Primary completion
Nov 22, 2024
Completion
Mar 31, 2025
Results posted
Feb 5, 2026
Last update
Feb 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion